Back to Authors

Saleh, Omar Abu

https://orcid.org/0000-0003-4955-5544

Mayo Clinic

Mayo Clinic

Citations 137

Left Ventricular Assist Device Infections: A Systematic Review
O’Horo, John C. , Saleh, Omar Abu , Stulak, John M., Wilhelm, Mark , Sohail, M. Rizwan , Abu Saleh, Omar M, Wilhelm, Mark P, Sohail, M Rizwan , O'Horo, John C , Baddour, Larry M.

ASAIO Journal | November 3, 2017 | Volume: 64 | Issue: 3 | Pages: 287-294

10.1097/mat.0000000000000684 Get It

Left ventricular assist devices (LVADs) are becoming a more frequent life-support intervention. Gaining an understanding of risk factors for infection and management strategies is important for treating these patients. We conducted a systematic review and meta-analysis of studies describing infections in continuous-flow LVADs. We evaluated incidence, risk factors, associated microorganisms, and outcomes by type of device and patient characteristics. Our search identified 90 distinct studies that reported LVAD infections and outcomes. Younger age and higher body mass index were associated with higher rates of LVAD infections. Driveline infections were the most common infection reported and the easiest to treat with fewest long-term consequences. Bloodstream infections were not reported as often, but they were associated with stroke and mortality. Treatment strategies varied and did not show a consistent best approach. LVAD infections are a significant cause of morbidity and mortality in LVAD patients. Most research comes from secondary analyses of other LVAD studies. The lack of infection-oriented research leaves several areas understudied. In particular, bloodstream infections in this population merit further research. Providers need more research studies to make evidence-based decisions about the prevention and treatment of LVAD infections.
Efficacy of Antitoxin Therapy in Treating Patients With Foodborne Botulism: A Systematic Review and Meta-analysis of Cases, 1923–2016
O’Horo, John C. , Harper, Eugene P. , Rafei, Abdelghani El , Ali, Rashid , Sakusic, Amra , Saleh, Omar Abu , Marcelin, Jasmine R , Rao, Agam K. , Sobel, Jeremy, Tosh, Pritish K. , El Rafei, Abdelghani, Abu Saleh, Omar M, Tan, Eugene M. , Marcelin, Jasmine , O'Horo, John C , DeSimone, Daniel C.

Clinical Infectious Diseases | September 13, 2017 | Volume: 66 | Issue: suppl_1 | Pages: S43-S56

10.1093/cid/cix815 Get It

Coadministration of Liposomal Amphotericin B and Contrast Medium Does Not Increase Risk of Kidney Injury
O’Horo, John C. , Osmon, Douglas R. , Saleh, Omar Abu , Marcelin, Jasmine R , Gharaibeh, Kamel A. , Hamadah, Abdurrahman , Barwise, Amelia , Kayhart, Bryce M., McDonald, Robert J. , McDonald, Jennifer S. , Leung, Nelson , Marcelin, Jasmine , Barwise, Amelia K , O'Horo, John C

Antimicrobial Agents and Chemotherapy | May 23, 2017 | Volume: 61 | Issue: 8 | Pages: No page available

10.1128/aac.00323-17 Get It

ABSTRACT Intravenous radiographic contrast medium and amphotericin B are commonly required in the care of patients with fungal infections. Both interventions have proposed nephrotoxicity through similar mechanisms. We systematically examined patients who received coadministration of liposomal amphotericin B (AmBisome; GE Healthcare) and intravenous contrast medium within a 24-h period and compared the results for those patients with the results for patients who underwent non-contrast medium studies. We found 114 cases and 85 controls during our study period. Overall, no increased risk of renal injury was seen with coadministration of these 2 agents. Adjustment for age, baseline kidney function, and other clinical factors through propensity score adjustment did not change this result. Our observations suggest that, when clinically indicated, coadministration of contrast medium and liposomal amphotericin B does not present excess risk compared with that from the administration of liposomal amphotericin B alone.
Development of High-Grade Daptomycin Resistance in a Patient Being Treated for Corynebacterium striatum Infection
AJMAL, SAIRA, Saleh, Omar Abu , Beam, Elena

Antimicrobial Agents and Chemotherapy | May 9, 2017 | Volume: 61 | Issue: 7 | Pages: No page available

10.1128/aac.00705-17 Get It

How Do We Treat Human Herpesvirus 6 Infection After Allogeneic Hematopoietic Stem Cell transplantation?
Aburjania, Nana , Saleh, Omar Abu , Razonable, Raymund R.

Future Virology | February 20, 2017 | Volume: 12 | Issue: 3 | Pages: 85-88

10.2217/fvl-2016-0140 Get It

Hypokalemia and Hypertension Associated with Supratherapeutic Posaconazole Levels
Mahmood, Maryam , Saleh, Omar Abu , Sohail, M. Rizwan , Abu Saleh, Omar , Sohail, M Rizwan , Mahmood, Maryam

Antimicrobial Agents and Chemotherapy | February 7, 2017 | Volume: 61 | Issue: 4 | Pages: No page available

10.1128/aac.00019-17 Get It

Disseminated Mycobacterium chimaera Infection After Cardiothoracic Surgery
Tan, Nicholas Y. , Sampath, Rahul , Saleh, Omar Abu , Jevremović, Dragan , Alniemi, Saba T. , Wengenack, Nancy L. , Sampathkumar, Priya , Badley, Andrew D. , Tweet, Marysia S. , Jevremovic, Dragan , Badley, Andrew D

Open Forum Infectious Diseases | June 17, 2016 | Volume: 3 | Issue: 3 | Pages: No page available

10.1093/ofid/ofw131 Get It

Abstract Ten case reports of disseminated Mycobacterium chimaera infections associated with cardiovascular surgery were published from Europe. We report 3 cases of disseminated M chimaera infections with histories of aortic graft and/or valvular surgery within the United States. Two of 3 patients demonstrated ocular involvement, a potentially important clinical finding.